PER
Click for more information
0.00% 9.0¢ percheron therapeutics limited

Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    27/06/23
    16:06
    Post #: 68494498
    Likes Created with Sketch. 38  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

INF Infinity Lithium on the brink of full approval for San Jose project in Extremadura, Spain
right-arrow Created with Sketch.
NEWS Seek and ye shall reap reward is this week's maxim
right-arrow Created with Sketch.
SS1 Drill, drill, drill: 3 explorers with news on Friday – Sun Silver, Aurelia & PNX Metals
right-arrow Created with Sketch.
RAC Race delivers promising results in cancer drug mice research into heart complications
right-arrow Created with Sketch.
RCE Recce wraps up IV UTI trial with fastest infusion times yet; key safety review inbound
right-arrow Created with Sketch.
NEWS Conference preview: Sprott founder Rick Rule shares his secrets to investing in commodities
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $81.13M
Open High Low Value Volume
8.9¢ 9.2¢ 8.8¢ $54.27K 599.6K

Buyers (Bids)

No. Vol. Price($)
4 133829 9.0¢
 

Sellers (Offers)

Price($) Vol. No.
9.1¢ 30094 1
View Market Depth
Last trade - 12.38pm 14/06/2024 (20 minute delay) ?
Last
9.1¢ 		  Change
0.000 ( 2.25 %)
Open High Low Volume
8.9¢ 9.1¢ 8.8¢ 122574
Last updated 12.19pm 14/06/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.